NCT00339131
- Conditions
- Adenocarcinoma, Carcinoid, Carcinoid Tumor, +10 more
- Locations
-
Not specified
Clinical trial condition
Paraganglioma
Explore clinical trials studying Paraganglioma. Study availability and eligibility vary by location and protocol.
70 public trials
27 recruiting studies
Paraganglioma trial results
Active, Not Recruiting
Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
NCT02721732
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +59 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
NCT02834013
- Conditions
- Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
Active, Not Recruiting
Testing the Addition of an Anticancer Drug, Olaparib, to the Usual Chemotherapy (Temozolomide) for Advanced Neuroendocrine Cancer
NCT04394858
- Conditions
- Advanced Adrenal Gland Pheochromocytoma, Advanced Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma, +13 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
Active, Not Recruiting
DOTATOC PET/CT for Imaging NET Patients
NCT03583528
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +66 more
- Locations
-
- BC Cancer Vancouver, British Columbia, Canada
Active, Not Recruiting
Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Pheochromocytoma/Paraganglioma
NCT03839498
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +5 more
- Locations
-
- Columbia University Irving Medical Center New York, United States
Active, Not Recruiting
LAnreotide in Metastatic Pheochromocytoma / PARAganglioma (LAMPARA)
NCT03946527
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +5 more
- Locations
-
- Columbia University Irving Medical Center New York, United States
- Cleveland Clinic Cleveland, Ohio, United States
Active, Not Recruiting
Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs
NCT04711135
- Conditions
- Gastro-enteropancreatic neuroendocrine tumor, Gastroenteropancreatic Neuroendocrine Tumors, Neoplasms, +7 more
- Locations
-
- University of Kentucky Lexington, Kentucky, United States
- Cincinnati Children's Hospital Cincinnati, Ohio, United States
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
- Centre Léon Berard Lyon, France
Active, Not Recruiting
Testing the Combination of Anti-Cancer Drugs Talazoparib and Temozolomide in Patients With Advanced Stage Rare Cancers, RARE 2 Trial
NCT05142241
- Conditions
- Adrenal Gland Pheochromocytoma, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm, +8 more
- Locations
-
- National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Active, Not Recruiting
Prognostic's Factors of Head and Neck Paragangliomas Evolution
NCT05233878
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
- Locations
-
- Fédération d'endocrinologie Hôpital Cardiologique/Groupement Hospitalier Est Bron, France